Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 464 entries
Sorted by: Best Match Show Resources per page
Guidelines for constructing master-list, six-option "insight" test questions.

Nursing outlook

Shields M.
PMID: 5205580
Nurs Outlook. 1971 Apr;19(4):274-6.

No abstract available.

Cite
Shields M. Guidelines for constructing master-list, six-option "insight" test questions. Nurs Outlook. 1971;19(4):274-6
Shields, M. (1971). Guidelines for constructing master-list, six-option "insight" test questions. Nursing outlook, 19(4), 274-6.
Shields, M. "Guidelines for constructing master-list, six-option "insight" test questions." Nursing outlook vol. 19,4 (1971): 274-6.
Shields M. Guidelines for constructing master-list, six-option "insight" test questions. Nurs Outlook. 1971 Apr;19(4):274-6. PMID: 5205580.
Copy Download .nbib Format: NLM
Adapting to a US Medical Curriculum in Malaysia: A Qualitative Study on Cultural Dissonance in International Education.

Cureus

Shilkofski N, Shields RY.
PMID: 27672530
Cureus. 2016 Aug 16;8(8):e739. doi: 10.7759/cureus.739.

CONTEXT: Minimal research has examined the recent exportation of medical curricula to international settings. Johns Hopkins University School of Medicine in Baltimore, USA partnered with Perdana University Graduate School of Medicine in Kuala Lumpur, Malaysia and implemented the same...

Cite
Shilkofski N, Shields RY. Adapting to a US Medical Curriculum in Malaysia: A Qualitative Study on Cultural Dissonance in International Education. Cureus. 2016;8(8):e739doi: 10.7759/cureus.739.
Shilkofski, N., & Shields, R. Y. (2016). Adapting to a US Medical Curriculum in Malaysia: A Qualitative Study on Cultural Dissonance in International Education. Cureus, 8(8), e739. https://doi.org/10.7759/cureus.739
Shilkofski, Nicole, and Shields, Ryan Y. "Adapting to a US Medical Curriculum in Malaysia: A Qualitative Study on Cultural Dissonance in International Education." Cureus vol. 8,8 (2016): e739. doi: https://doi.org/10.7759/cureus.739
Shilkofski N, Shields RY. Adapting to a US Medical Curriculum in Malaysia: A Qualitative Study on Cultural Dissonance in International Education. Cureus. 2016 Aug 16;8(8):e739. doi: 10.7759/cureus.739. PMID: 27672530; PMCID: PMC5026498.
Copy Download .nbib Format: NLM
L'émergence de la thérapeutique de précision: de nouveaux défis et de nouvelles possibilités pour les leaders en santé du Canada.

Healthcare management forum

Slater J, Shields L, Racette RJ, Juzwishin D, Coppes M.
PMID: 26487732
Healthc Manage Forum. 2015 Nov;28(6):S40-6. doi: 10.1177/0840470415607256. Epub 2015 Oct 19.

À l'ère de la médecine personnalisée et de la médecine de précision, l'approche envers les soins est en rapide mutation. Les cliniciens exigent de plus en plus d'information génétique et moléculaire et les patients s'attendent à la fournir pour...

Cite
Slater J, Shields L, Racette RJ, et al. L'émergence de la thérapeutique de précision: de nouveaux défis et de nouvelles possibilités pour les leaders en santé du Canada. Healthc Manage Forum. 2015;28(6):S40-6doi: 10.1177/0840470415607256.
Slater, J., Shields, L., Racette, R. J., Juzwishin, D., & Coppes, M. (2015). L'émergence de la thérapeutique de précision: de nouveaux défis et de nouvelles possibilités pour les leaders en santé du Canada. Healthcare management forum, 28(6), S40-6. https://doi.org/10.1177/0840470415607256
Slater, Jim, et al. "L'émergence de la thérapeutique de précision: de nouveaux défis et de nouvelles possibilités pour les leaders en santé du Canada." Healthcare management forum vol. 28,6 (2015): S40-6. doi: https://doi.org/10.1177/0840470415607256
Slater J, Shields L, Racette RJ, Juzwishin D, Coppes M. L'émergence de la thérapeutique de précision: de nouveaux défis et de nouvelles possibilités pour les leaders en santé du Canada. Healthc Manage Forum. 2015 Nov;28(6):S40-6. doi: 10.1177/0840470415607256. Epub 2015 Oct 19. PMID: 26487732.
Copy Download .nbib Format: NLM
Purely antiferromagnetic magnetoelectric random access memory.

Nature communications

Kosub T, Kopte M, Hühne R, Appel P, Shields B, Maletinsky P, Hübner R, Liedke MO, Fassbender J, Schmidt OG, Makarov D.
PMID: 28045029
Nat Commun. 2017 Jan 03;8:13985. doi: 10.1038/ncomms13985.

Magnetic random access memory schemes employing magnetoelectric coupling to write binary information promise outstanding energy efficiency. We propose and demonstrate a purely antiferromagnetic magnetoelectric random access memory (AF-MERAM) that offers a remarkable 50-fold reduction of the writing threshold compared...

Cite
Kosub T, Kopte M, Hühne R, et al. Purely antiferromagnetic magnetoelectric random access memory. Nat Commun. 2017;8:13985doi: 10.1038/ncomms13985.
Kosub, T., Kopte, M., Hühne, R., Appel, P., Shields, B., Maletinsky, P., Hübner, R., Liedke, M. O., Fassbender, J., Schmidt, O. G., & Makarov, D. (2017). Purely antiferromagnetic magnetoelectric random access memory. Nature communications, 813985. https://doi.org/10.1038/ncomms13985
Kosub, Tobias, et al. "Purely antiferromagnetic magnetoelectric random access memory." Nature communications vol. 8 (2017): 13985. doi: https://doi.org/10.1038/ncomms13985
Kosub T, Kopte M, Hühne R, Appel P, Shields B, Maletinsky P, Hübner R, Liedke MO, Fassbender J, Schmidt OG, Makarov D. Purely antiferromagnetic magnetoelectric random access memory. Nat Commun. 2017 Jan 03;8:13985. doi: 10.1038/ncomms13985. PMID: 28045029; PMCID: PMC5216083.
Copy Download .nbib Format: NLM
Crystal structure of nitrido[5,10,15,20-tetra-kis(4-methylphenyl)-porphyrinato]-manganese(V).

Acta crystallographica. Section E, Structure reports online

Shields MR, Guzei IA, Goll JG.
PMID: 25484663
Acta Crystallogr Sect E Struct Rep Online. 2014 Sep 24;70:242-5. doi: 10.1107/S1600536814020558. eCollection 2014 Oct 01.

The title compound, [Mn(C48H36N4)(N)], is a manganese(V) complex with the transition metal in a square-pyramidal coordination geometry and a nitride as the axial ligand. The complex resides on a crystallographic inversion center and only one half of it is...

Cite
Shields MR, Guzei IA, Goll JG. Crystal structure of nitrido[5,10,15,20-tetra-kis(4-methylphenyl)-porphyrinato]-manganese(V). Acta Crystallogr Sect E Struct Rep Online. 2014;70:242-5doi: 10.1107/S1600536814020558.
Shields, M. R., Guzei, I. A., & Goll, J. G. (2014). Crystal structure of nitrido[5,10,15,20-tetra-kis(4-methylphenyl)-porphyrinato]-manganese(V). Acta crystallographica. Section E, Structure reports online, 70242-5. https://doi.org/10.1107/S1600536814020558
Shields, Mason R, et al. "Crystal structure of nitrido[5,10,15,20-tetra-kis(4-methylphenyl)-porphyrinato]-manganese(V)." Acta crystallographica. Section E, Structure reports online vol. 70 (2014): 242-5. doi: https://doi.org/10.1107/S1600536814020558
Shields MR, Guzei IA, Goll JG. Crystal structure of nitrido[5,10,15,20-tetra-kis(4-methylphenyl)-porphyrinato]-manganese(V). Acta Crystallogr Sect E Struct Rep Online. 2014 Sep 24;70:242-5. doi: 10.1107/S1600536814020558. eCollection 2014 Oct 01. PMID: 25484663; PMCID: PMC4257217.
Copy Download .nbib Format: NLM
Patient-reported outcomes are changing the landscape in oncology care: challenges and opportunities for payers.

American health & drug benefits

Zagadailov E, Fine M, Shields A.
PMID: 24991362
Am Health Drug Benefits. 2013 Jul;6(5):264-74.

BACKGROUND: A patient-reported outcome (PRO) is a subjective report that comes from a patient without interpretation by a clinician. Because of the increasingly significant role of PROs in the development and evaluation of new medicines, the US Food and...

Cite
Zagadailov E, Fine M, Shields A. Patient-reported outcomes are changing the landscape in oncology care: challenges and opportunities for payers. Am Health Drug Benefits. 2013;6(5):264-74
Zagadailov, E., Fine, M., & Shields, A. (2013). Patient-reported outcomes are changing the landscape in oncology care: challenges and opportunities for payers. American health & drug benefits, 6(5), 264-74.
Zagadailov, Erin, et al. "Patient-reported outcomes are changing the landscape in oncology care: challenges and opportunities for payers." American health & drug benefits vol. 6,5 (2013): 264-74.
Zagadailov E, Fine M, Shields A. Patient-reported outcomes are changing the landscape in oncology care: challenges and opportunities for payers. Am Health Drug Benefits. 2013 Jul;6(5):264-74. PMID: 24991362; PMCID: PMC4031715.
Copy Download .nbib Format: NLM
The association of foot structure and footwear fit with disability in children and adolescents with Down syndrome.

Journal of foot and ankle research

Lim PQ, Shields N, Nikolopoulos N, Barrett JT, Evans AM, Taylor NF, Munteanu SE.
PMID: 25722747
J Foot Ankle Res. 2015 Feb 12;8:4. doi: 10.1186/s13047-015-0062-0. eCollection 2015.

BACKGROUND: Foot deformity, flat feet, and the use of ill-fitting footwear are common in children and adolescents with Down syndrome (DS). The aim of this study was to determine whether these observations are associated with foot-specific disability in this...

Cite
Lim PQ, Shields N, Nikolopoulos N, et al. The association of foot structure and footwear fit with disability in children and adolescents with Down syndrome. J Foot Ankle Res. 2015;8:4doi: 10.1186/s13047-015-0062-0.
Lim, P. Q., Shields, N., Nikolopoulos, N., Barrett, J. T., Evans, A. M., Taylor, N. F., & Munteanu, S. E. (2015). The association of foot structure and footwear fit with disability in children and adolescents with Down syndrome. Journal of foot and ankle research, 84. https://doi.org/10.1186/s13047-015-0062-0
Lim, Polly Qx, et al. "The association of foot structure and footwear fit with disability in children and adolescents with Down syndrome." Journal of foot and ankle research vol. 8 (2015): 4. doi: https://doi.org/10.1186/s13047-015-0062-0
Lim PQ, Shields N, Nikolopoulos N, Barrett JT, Evans AM, Taylor NF, Munteanu SE. The association of foot structure and footwear fit with disability in children and adolescents with Down syndrome. J Foot Ankle Res. 2015 Feb 12;8:4. doi: 10.1186/s13047-015-0062-0. eCollection 2015. PMID: 25722747; PMCID: PMC4342196.
Copy Download .nbib Format: NLM
Antibody Responses After Analytic Treatment Interruption in Human Immunodeficiency Virus-1-Infected Individuals on Early Initiated Antiretroviral Therapy.

Open forum infectious diseases

Stephenson KE, Neubauer GH, Bricault CA, Shields J, Bayne M, Reimer U, Pawlowski N, Knaute T, Zerweck J, Seaman MS, Rosenberg ES, Barouch DH.
PMID: 27419172
Open Forum Infect Dis. 2016 May 19;3(2):ofw100. doi: 10.1093/ofid/ofw100. eCollection 2016 Apr.

The examination of antibody responses in human immunodeficiency virus (HIV)-1-infected individuals in the setting of antiretroviral treatment (ART) interruption can provide insight into the evolution of antibody responses during viral rebound. In this study, we assessed antibody responses in...

Cite
Stephenson KE, Neubauer GH, Bricault CA, et al. Antibody Responses After Analytic Treatment Interruption in Human Immunodeficiency Virus-1-Infected Individuals on Early Initiated Antiretroviral Therapy. Open Forum Infect Dis. 2016;3(2):ofw100doi: 10.1093/ofid/ofw100.
Stephenson, K. E., Neubauer, G. H., Bricault, C. A., Shields, J., Bayne, M., Reimer, U., Pawlowski, N., Knaute, T., Zerweck, J., Seaman, M. S., Rosenberg, E. S., & Barouch, D. H. (2016). Antibody Responses After Analytic Treatment Interruption in Human Immunodeficiency Virus-1-Infected Individuals on Early Initiated Antiretroviral Therapy. Open forum infectious diseases, 3(2), ofw100. https://doi.org/10.1093/ofid/ofw100
Stephenson, Kathryn E, et al. "Antibody Responses After Analytic Treatment Interruption in Human Immunodeficiency Virus-1-Infected Individuals on Early Initiated Antiretroviral Therapy." Open forum infectious diseases vol. 3,2 (2016): ofw100. doi: https://doi.org/10.1093/ofid/ofw100
Stephenson KE, Neubauer GH, Bricault CA, Shields J, Bayne M, Reimer U, Pawlowski N, Knaute T, Zerweck J, Seaman MS, Rosenberg ES, Barouch DH. Antibody Responses After Analytic Treatment Interruption in Human Immunodeficiency Virus-1-Infected Individuals on Early Initiated Antiretroviral Therapy. Open Forum Infect Dis. 2016 May 19;3(2):ofw100. doi: 10.1093/ofid/ofw100. eCollection 2016 Apr. PMID: 27419172; PMCID: PMC4943535.
Copy Download .nbib Format: NLM
MDMA toxicity: no evidence for a major influence of metabolic genotype at CYP2D6.

Addiction biology

O'Donohoe A, O'Flynn K, Shields K, Hawi Z, Gill M.
PMID: 26734924
Addict Biol. 1998 Jul;3(3):309-14. doi: 10.1080/13556219872119.

3,4 Methylenedioxymethamphetamine (MDMA or ecstasy) has become a major drug of abuse over the last decade. It produces a mixture of systemic and neuropsychological effects. Animal studies show a range of short- and long-term toxic effects, both systemically and...

Cite
O'Donohoe A, O'Flynn K, Shields K, et al. MDMA toxicity: no evidence for a major influence of metabolic genotype at CYP2D6. Addict Biol. 1998;3(3):309-14doi: 10.1080/13556219872119.
O'Donohoe, A., O'Flynn, K., Shields, K., Hawi, Z., & Gill, M. (1998). MDMA toxicity: no evidence for a major influence of metabolic genotype at CYP2D6. Addiction biology, 3(3), 309-14. https://doi.org/10.1080/13556219872119
O'Donohoe, A, et al. "MDMA toxicity: no evidence for a major influence of metabolic genotype at CYP2D6." Addiction biology vol. 3,3 (1998): 309-14. doi: https://doi.org/10.1080/13556219872119
O'Donohoe A, O'Flynn K, Shields K, Hawi Z, Gill M. MDMA toxicity: no evidence for a major influence of metabolic genotype at CYP2D6. Addict Biol. 1998 Jul;3(3):309-14. doi: 10.1080/13556219872119. PMID: 26734924.
Copy Download .nbib Format: NLM
Chloroplast DNA evolution and the origin of amphidiploid Brassica species.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik

Palmer JD, Shields CR, Cohen DB, Orton TJ.
PMID: 24263412
Theor Appl Genet. 1983 May;65(3):181-9. doi: 10.1007/BF00308062.

The origin and evolution of a hybrid species complex in the genus Brassica (cabbage, turnip, mustard, rapeseed oil) has been explored through mutational analysis of the maternally inherited chloroplast genome. A detailed chloroplast DNA phylogeny enables identification of the...

Cite
Palmer JD, Shields CR, Cohen DB, et al. Chloroplast DNA evolution and the origin of amphidiploid Brassica species. Theor Appl Genet. 1983;65(3):181-9doi: 10.1007/BF00308062.
Palmer, J. D., Shields, C. R., Cohen, D. B., & Orton, T. J. (1983). Chloroplast DNA evolution and the origin of amphidiploid Brassica species. TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik, 65(3), 181-9. https://doi.org/10.1007/BF00308062
Palmer, J D, et al. "Chloroplast DNA evolution and the origin of amphidiploid Brassica species." TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik vol. 65,3 (1983): 181-9. doi: https://doi.org/10.1007/BF00308062
Palmer JD, Shields CR, Cohen DB, Orton TJ. Chloroplast DNA evolution and the origin of amphidiploid Brassica species. Theor Appl Genet. 1983 May;65(3):181-9. doi: 10.1007/BF00308062. PMID: 24263412.
Copy Download .nbib Format: NLM
Assessing Physicochemical Properties of Drug Molecules via Microsolvation Measurements with Differential Mobility Spectrometry.

ACS central science

Liu C, Le Blanc JC, Schneider BB, Shields J, Federico JJ, Zhang H, Stroh JG, Kauffman GW, Kung DW, Ieritano C, Shepherdson E, Verbuyst M, Melo L, Hasan M, Naser D, Janiszewski JS, Hopkins WS, Campbell JL.
PMID: 28280776
ACS Cent Sci. 2017 Feb 22;3(2):101-109. doi: 10.1021/acscentsci.6b00297. Epub 2017 Feb 10.

The microsolvated state of a molecule, represented by its interactions with only a small number of solvent molecules, can play a key role in determining the observable bulk properties of the molecule. This is especially true in cases where...

Cite
Liu C, Le Blanc JC, Schneider BB, et al. Assessing Physicochemical Properties of Drug Molecules via Microsolvation Measurements with Differential Mobility Spectrometry. ACS Cent Sci. 2017;3(2):101-109doi: 10.1021/acscentsci.6b00297.
Liu, C., Le Blanc, J. C., Schneider, B. B., Shields, J., Federico, J. J., Zhang, H., Stroh, J. G., Kauffman, G. W., Kung, D. W., Ieritano, C., Shepherdson, E., Verbuyst, M., Melo, L., Hasan, M., Naser, D., Janiszewski, J. S., Hopkins, W. S., & Campbell, J. L. (2017). Assessing Physicochemical Properties of Drug Molecules via Microsolvation Measurements with Differential Mobility Spectrometry. ACS central science, 3(2), 101-109. https://doi.org/10.1021/acscentsci.6b00297
Liu, Chang, et al. "Assessing Physicochemical Properties of Drug Molecules via Microsolvation Measurements with Differential Mobility Spectrometry." ACS central science vol. 3,2 (2017): 101-109. doi: https://doi.org/10.1021/acscentsci.6b00297
Liu C, Le Blanc JC, Schneider BB, Shields J, Federico JJ, Zhang H, Stroh JG, Kauffman GW, Kung DW, Ieritano C, Shepherdson E, Verbuyst M, Melo L, Hasan M, Naser D, Janiszewski JS, Hopkins WS, Campbell JL. Assessing Physicochemical Properties of Drug Molecules via Microsolvation Measurements with Differential Mobility Spectrometry. ACS Cent Sci. 2017 Feb 22;3(2):101-109. doi: 10.1021/acscentsci.6b00297. Epub 2017 Feb 10. PMID: 28280776; PMCID: PMC5324087.
Copy Download .nbib Format: NLM
Automatic detection of molecular symmetry in the Cambridge Structural Database.

Acta crystallographica. Section B, Structural science

Cole JC, Yao JW, Shields GP, Motherwell WD, Allen FH, Howard JA.
PMID: 11173371
Acta Crystallogr B. 2001 Feb;57:88-94. doi: 10.1107/s010876810001380x.

A method for the detection of approximate molecular symmetry in crystal structures has been developed. The point-group symmetry is assigned to each molecule and the relevant symmetry elements can be visualized, superimposed on the molecule. The method has been...

Cite
Cole JC, Yao JW, Shields GP, et al. Automatic detection of molecular symmetry in the Cambridge Structural Database. Acta Crystallogr B. 2001;57:88-94doi: 10.1107/s010876810001380x.
Cole , J. C., Yao , J. W., Shields , G. P., Motherwell , W. D., Allen , F. H., & Howard , J. A. (2001). Automatic detection of molecular symmetry in the Cambridge Structural Database. Acta crystallographica. Section B, Structural science, 5788-94. https://doi.org/10.1107/s010876810001380x
Cole , J C, et al. "Automatic detection of molecular symmetry in the Cambridge Structural Database." Acta crystallographica. Section B, Structural science vol. 57 (2001): 88-94. doi: https://doi.org/10.1107/s010876810001380x
Cole JC, Yao JW, Shields GP, Motherwell WD, Allen FH, Howard JA. Automatic detection of molecular symmetry in the Cambridge Structural Database. Acta Crystallogr B. 2001 Feb;57:88-94. doi: 10.1107/s010876810001380x. PMID: 11173371.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 464 entries